Consistent execution of strategy and strong fourth quarter performance has resulted in organic revenue growth of 16.2% for FY 2022Organic growth in adjusted EBITDA of 10.2% for FY 2022, ahead
EQS-News: Gerresheimer AG / Key word(s): Annual Results/Quarter ResultsGerresheimer AG: Gerresheimer 2022: Profitable growth company boosting revenue and adjusted EBITDA growth to double-digit levels 23.02.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Gerresheimer 2022: P.
/PRNewswire/ Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reports.
Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, confirms guidance for its financial year 2022 (FY22) after another
Gerresheimer AG (OTCPK:GRRMF) Q3 2022 Earnings Conference Call October 12, 2022 4:00 AM ET Company Participants Carolin Nadilo - Head of Investor Relations Dietmar Siemssen - Chief.